GESTEIGERTE IMMUNOGENITAET VON PLASMAMEMBRANEN VACCINIAVIRUSINFIZIERTER BHK-ZELLEN = AUGMENTATION DE L'IMMUNOGENICITE DES MEMBRANES PLASMIQUES DES CELLULES BHK INFECTEES PAR LE VIRUS DE LA VACCINEBANDLOW G; KOSZINOWSKI U; THOMSSEN R et al.1973; ARCH. GES. VIRUSFORSCH.,; OESTERR.; DA. 1973; VOL. 40; NO 1-2; PP. 63-71; ABS. ANGL.; BIBL. 1P.Serial Issue

Strategies for the preclinical and clinical characterization of immunogenicityKOREN, E; MYTYCH, D; KOSCEC, M et al.Developments in biologicals. 2005, Vol 122, pp 195-200, issn 1424-6074, 6 p.Conference Paper

Interchangeability, immunogenicity and biosimilarsEBBERS, Hans C; CROW, Stacy A; VULTO, Arnold G et al.Nature biotechnology (Print). 2012, Vol 30, Num 12, pp 1186-1190, issn 1087-0156, 5 p.Article

A randomized study of a flexible booster dosing regimen of VAQTA® in adults: safety, tolerability, and immunogenicityHORNICK, Richard; TUCKER, Richard; KAPLAN, Karen M et al.Vaccine. 2001, Vol 19, Num 32, pp 4727-4731, issn 0264-410XArticle

THE EFFECT OF THE IMMUNOGENICITY OF THE HETEROLOGOUS CARRIER ON THE EARLY SECONDARY ANTI-2,4-DINITROPHENYL (DNP) RESPONSE OF BALB/C MICE = INFLUENCE DE L'IMMUNOGENICITE DU SUPPORT HETEROLOGUE SUR LA REPONSE SECONDAIRE PRECOCE ANTI-DINITRO 2,4 PHENYL (DNP) DES SOURIS BALB/CHAVAS HF; PICKARD AR.1972; J. IMMUNOL.; U.S.A.; DA. 1972; VOL. 109; NO 4; PP. 791-800; BIBL. 21REF.Serial Issue

Fungal vaccines and immunotherapySEGAL, E; ELAD, D.Journal de mycologie médicale (Paris). 2006, Vol 16, Num 3, pp 134-151, issn 1156-5233, 18 p.Article

Allergens of lanolin. II: Allergenicity of synthetic alkane-α, β-diols and alkane-α, ω-diolsTAKANO, S; YAMANAKA, M; OKAMOTO, K et al.Journal of the Society of Cosmetic Chemists. 1983, Vol 34, Num 2, pp 116-125, issn 0037-9832Article

Enhanced immunogenicity of a contraceptive vaccine using diverse synthetic carriers with permissible adjuvantGUPTA, Anushree; PAL, Rahul; AHLAWAT, Sarita et al.Vaccine. 2001, Vol 19, Num 25-26, pp 3384-3389, issn 0264-410XArticle

A parallel approach to the discovery of carrier delivery vehicles to enhance antigen immunogenicityDELGADO, Mercedes; KYUNG JOO LEE; ALTOBELL, Lawrence III et al.Journal of the American Chemical Society. 2002, Vol 124, Num 18, pp 4946-4947, issn 0002-7863Article

Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvantsLOWELL, G. H; SMITH, L. F; SEID, R. C et al.The Journal of experimental medicine. 1988, Vol 167, Num 2, pp 658-663, issn 0022-1007Article

COMPARATIVE IMMUNOGENICITY OF HEAT-KILLED AND LIVING ORAL SALMONELLA VACCINESCOLLINS FM; CARTER PB.1972; INFECT. AND IMMUN.; U.S.A.; DA. 1972; VOL. 6; NO 4; PP. 451-458; BIBL. 1 P.Serial Issue

CARACTERE POLYMERIQUE D'UNE MOLECULE D'ANTIGENE EN TANT QUE FACTEUR DETERMINANT LE MODE DE L'ACTIVITE IMMUNOGENELYASHENKO VA.1976; ZH. MIKROBIOL. EPIDEMIOL. IMMUNOBIOL.; S.S.S.R.; DA. 1976; NO 6; PP. 3-11; BIBL. 1 P. 1/2Article

DETERMINATION DE L'ACTIVITE SPECIFIQUE DES VACCINS ANTIRABIQUES D'APRES LE DEGRE D'ADSORPTION DES ANTICORPSMAD'YAROVA RS; NIKOLAEVA NV; MOROGOVA VM et al.1973; VOPR. VIRUSOL.; S.S.S.R.; DA. 1973; NO 1; PP. 77-82; ABS. ANGL.; BIBL. 4REF.Serial Issue

THE IMMUNOGENICITY OF A LOW MOLECULAR WEIGHT SYNTHETIC POLYPEPTIDECALLAHAN HJ; MAURER PH.1973; IMMUNOCHEMISTRY; G.B.; DA. 1973; VOL. 10; NO 3; PP. 205-207; BIBL. 18REF.Serial Issue

IMMUNOGENE PHYTOANTIGENE = LES PHYTOANTIGENES IMMUNOGENESREIMANN W.1972; Z. RECHTSMED.; DTSCH.; DA. 1972; VOL. 71; NO 3; PP. 243-245; ABS. ANGL.; BIBL. 6REF.Serial Issue

THE AUTO-IMMUNOGENICITY OF ARTICULAR CARTILAGELANGER F; GROSS AE; GREAVES MF et al.1972; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1972; VOL. 12; NO 1; PP. 31-37; BIBL. 21REF.Serial Issue

Immunogenicity assessment in non-clinical studiesSWANSON, Steven J; BUSSIERE, Jeanine.Current opinion in microbiology. 2012, Vol 15, Num 3, pp 337-347, issn 1369-5274, 11 p.Article

Biosimilars in rheumatology: pharmacological and pharmacoeconomic issuesLAPADULA, G; FERRACCIOLI, G. F.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 4, issn 0392-856X, S102-S106, SUP73Article

IN VITRO MORPHINE BINDING BY SERA FROM MORPHINE-TREATED RABBITS1972; J. IMMUNOL.; U.S.A.; DA. 1972; VOL. 109; NO 1; PP. 174-175; BIBL. 3REF.Serial Issue

Immunogenicity of xenopeptide hormone therapiesSCHNABEL, Catherine A; FINEBERG, S. Edwin; KIM, Dennis D et al.Peptides (New York, NY. 1980). 2006, Vol 27, Num 7, pp 1902-1910, issn 0196-9781, 9 p.Article

The immunogenicity of injectable collagen. I: A 1-year prospective studyCOOPERMAN, L; MICHAELI, D.Journal of the American Academy of Dermatology. 1984, Vol 10, Num 4, pp 638-646, issn 0190-9622Article

Immunogenicity of constitutively active ^vs99eBRafANDERSEN, Mads Hald; FENSTERLE, Joachim; STRATEN, Per Thor et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5456-5460, issn 0008-5472, 5 p.Article

Covalent complexes of antigen and α₂-macroglobulin : evidence for dramatically-increased immunogenicityCIANCIOLO, George J; ENGHILD, Jan J; PIZZO, Salvatore V et al.Vaccine. 2001, Vol 20, Num 3-4, pp 554-562, issn 0264-410XArticle

Propriétés immunogènes de souches épidémiques et de recombinants d'Influenzavirus H1N1 et H3N2SHCHIPANOVA, M. V; PODCHERNYAEVA, R. YA; BLINOVA, V. K et al.Voprosy virusologii. 1984, Vol 29, Num 3, pp 273-276, issn 0507-4088Article

Glycan-Dependent Immunogenicity of Recombinant Soluble Trimeric HemagglutininDE VRIES, Robert P; SMIT, Cornelis H; HOKKE, Cornelis H et al.Journal of virology. 2012, Vol 86, Num 21, pp 11735-11744, issn 0022-538X, 10 p.Article